Aytu Biopharma (AYTU) Current Leases (2019 - 2022)

Aytu Biopharma (AYTU) has 4 years of Current Leases data on file, last reported at $1.2 million in Q1 2022.

• Current Leases for Q1 2022 came in at $1.2 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2022 was $1.2 million (changed N/A YoY), and the FY2021 annual result was $940000.0, up 213.33% from the prior year.
• Current Leases climbed to $1.2 million in Q1 2022 per AYTU's latest filing, from $1.2 million in the prior quarter.
• Over five years, Current Leases peaked at $1.2 million in Q1 2022 and troughed at $79362.0 in Q3 2019.
• A 4-year average of $534907.6 and a median of $294619.0 in 2020 frame the typical range for Current Leases.
• The sharpest annual moves came in 2020 and 2021: Current Leases climbed 21.16% in 2020, then soared 1069.92% in 2021.
• A 4-year view of Current Leases shows it stood at $82755.0 in 2019, then rose by 21.16% to $100263.0 in 2020, then soared by 1069.92% to $1.2 million in 2021, then climbed by 2.56% to $1.2 million in 2022.
• Business Quant data shows AYTU's Current Leases at $1.2 million in Q1 2022, $1.2 million in Q4 2021, and $1.1 million in Q3 2021.